Steven Coutre, MD

    Steven Coutre, MD

    Professor of medicine in hematology at the Stanford University Medical Center in Stanford, California
    • Is Fludarabine Dead in CLL? Friday, May 1st, 2015

      A few short years ago, fludarabine was considered the gold standard of front-line treatment for chronic lymphocytic leukemia (CLL), providing better response rates than old standby, chlorambucil. Now, in an era of monoclonal antibodies and targeted therapies, fludarabine is losing its place as leader of the pack. ASH Clinical News has invited Steven Coutre, MD, [...]

    SHARE